Market Overview:
The global COVID-19 vaccines & therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of COVID-19, rising awareness about preventive measures, and technological advancements in vaccine development. The global COVID-19 vaccines & therapeutics market is segmented on the basis of type into vaccines and therapeutics. The vaccine segment is further sub-segmented into monovalent and multivalent vaccines. The therapeutic segment is further sub-segmented into antiviral drugs and other therapies. On the basis of application, the market is divided into children and adults. Geographically, it is analyzed across North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA). Some of the key players operating in this market are GlaxoSmithKline plc., Johnson & Johnson Services Inc., Sanofi Pasteur SA., Bavarian Nordic A/S., Emergent BioSolutions Inc.
Product Definition:
COVID-19 Vaccines & Therapeutics is the study and development of vaccines and treatments for the coronavirus disease 2019 (COVID-19). The importance of COVID-19 Vaccines & Therapeutics is that it could help to prevent or treat this new virus.
COVID-19 Vaccines:
The COVID-19 vaccines market is expected to witness significant growth over the forecast period owing to the rising number of people infected with coronavirus and increasing demand for immunization. The market is driven by factors such as growing government initiatives, high prevalence of chronic diseases leading to a rise in demand for vaccination. Moreover, increasing awareness among individuals regarding health and safety measures are also anticipated to boost the growth of this market during the forecast period.
COVID-19 Therapeutics:
COVID-19 Therapeutics market is expected to witness lucrative growth over the forecast period owing to increasing incidences of Covid-19 across the globe. The pandemic has created a massive impact on various industries such as pharmaceuticals, biotechnology, and medical devices. COVID-19 Therapeutics market is anticipated to grow rapidly due to rising R&D activities for developing novel drugs & vaccines for treatment against coronavirus disease (Covid-19).
Application Insights:
Based on the application, the global COVID-19 vaccines and therapeutics market is segmented into children, adult and others. The children segment held a major share in 2017 owing to high prevalence of COVID-19 in this population. According to WHO, over 300 thousand people have been affected by this disease worldwide with more than 10 thousand deaths reported till date.
The adult segment is expected to witness significant growth during the forecast period due to increasing incidence rate of new cases across various regions including Europe and America since 2018.
Regional Analysis:
North America dominated the global market in 2018 owing to the presence of a robust healthcare infrastructure, high awareness levels coupled with relatively higher per capita income and availability of funding for research and development. The region is expected to maintain its dominance throughout the forecast period due to continuous R&D activities by major companies as well as government-funded programs. For instance, in May 2019, Public Health England (PHE) launched a new program called Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV). This initiative focuses on accelerating clinical trials for therapeutics that target coronavirus infection along with vaccine development.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing investments by governments as well as private players in emerging economies including China and India. In addition, rising incidence of COVID 19 infections coupled with growing demand for preventive measures will boost product penetration rates across this region during the estimated time span.
Growth Factors:
- Increasing global prevalence of COVID-19: The increasing global prevalence of COVID-19 is one of the most important growth drivers for the COVID-19 vaccines & therapeutics market. According to a study by the World Health Organization (WHO), as of June 2019, more than 82,000 cases and 3,000 deaths due to COVID-19 have been reported in over 50 countries. This number is expected to increase in the coming years due to the increasing awareness about this virus and its potential dangers.
- Emergence of new vaccine candidates: The emergence of new vaccine candidates is another key growth driver for the COVID-19 vaccines & therapeutics market. A number of pharmaceutical companies are currently developing novel vaccine candidates that could be used for preventing or treating this virus. For instance, Inovio Pharmaceuticals Inc., Johnson & Johnson, Bavarian Nordic A/S, and others are working on various vaccine candidates that show promise against this virus.
- Growing demand for preventive measures: The growing demand for preventive measures is another major growth driver for the COVID-19 vaccines & therapeutics market. As people become increasingly aware about how dangerous this virus can be, they are looking for ways to protect themselves from it through vaccination or other means such as using face masks and hand sanitizers etc.. This growing demand is likely to drive significant growth in the overall market during forecast period 2020 – 2025..
Scope Of The Report
Report Attributes
Report Details
Report Title
COVID-19 Vaccines & Therapeutics Market Research Report
By Type
COVID-19 Vaccines, COVID-19 Therapeutics
By Application
Children, Adult
By Companies
Pfizer, Moderna Therapeutics, AstraZeneca, Janssen, Novavax, Gilead Sciences, Eli Lilly and Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global COVID-19 Vaccines & Therapeutics Market Report Segments:
The global COVID-19 Vaccines & Therapeutics market is segmented on the basis of:
Types
COVID-19 Vaccines, COVID-19 Therapeutics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adult
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Moderna Therapeutics
- AstraZeneca
- Janssen
- Novavax
- Gilead Sciences
- Eli Lilly and Company
Highlights of The COVID-19 Vaccines & Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- COVID-19 Vaccines
- COVID-19 Therapeutics
- By Application:
- Children
- Adult
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COVID-19 Vaccines & Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
COVID-19 is a novel coronavirus discovered in 2019. It is the ninth known human coronavirus and the first to be identified in 2019. There is currently no vaccine or treatment available for COVID-19.
Some of the major players in the covid-19 vaccines & therapeutics market are Pfizer, Moderna Therapeutics, AstraZeneca, Janssen, Novavax, Gilead Sciences, Eli Lilly and Company.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COVID-19 Vaccines & Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 COVID-19 Vaccines & Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 COVID-19 Vaccines & Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the COVID-19 Vaccines & Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global COVID-19 Vaccines & Therapeutics Market Size & Forecast, 2018-2028
4.5.1 COVID-19 Vaccines & Therapeutics Market Size and Y-o-Y Growth
4.5.2 COVID-19 Vaccines & Therapeutics Market Absolute $ Opportunity
Chapter 5 Global COVID-19 Vaccines & Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
5.2.1 COVID-19 Vaccines
5.2.2 COVID-19 Therapeutics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global COVID-19 Vaccines & Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adult
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COVID-19 Vaccines & Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COVID-19 Vaccines & Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America COVID-19 Vaccines & Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America COVID-19 Vaccines & Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
9.6.1 COVID-19 Vaccines
9.6.2 COVID-19 Therapeutics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adult
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe COVID-19 Vaccines & Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe COVID-19 Vaccines & Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
10.6.1 COVID-19 Vaccines
10.6.2 COVID-19 Therapeutics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adult
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific COVID-19 Vaccines & Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific COVID-19 Vaccines & Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
11.6.1 COVID-19 Vaccines
11.6.2 COVID-19 Therapeutics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adult
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America COVID-19 Vaccines & Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America COVID-19 Vaccines & Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
12.6.1 COVID-19 Vaccines
12.6.2 COVID-19 Therapeutics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adult
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) COVID-19 Vaccines & Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) COVID-19 Vaccines & Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) COVID-19 Vaccines & Therapeutics Market Size Forecast by Type
13.6.1 COVID-19 Vaccines
13.6.2 COVID-19 Therapeutics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) COVID-19 Vaccines & Therapeutics Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adult
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COVID-19 Vaccines & Therapeutics Market: Competitive Dashboard
14.2 Global COVID-19 Vaccines & Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Moderna Therapeutics
14.3.3 AstraZeneca
14.3.4 Janssen
14.3.5 Novavax
14.3.6 Gilead Sciences
14.3.7 Eli Lilly and Company
